25-27 Aug 2019

Krakow, Poland

ICE Kraków Congress Centre

Registration free until 01.08.2019

Bringing the world of cardiology together :

• 32,000 healthcare professionals
• From 150 countries
• 4,500 abstracts presented
• 500 experts sessions
• 400 cardiology topics
• 200 exhibiting companies
• 5 days of scientific sessions

More informations : click here 

The Pediatric and Primary Lymphedema WG (PPL WG) face-to-face meeting will take place on September 12-13th, 2019 in London. It will be lead by Dr Malou Van Zanten (PPL WG member from HCP St Georges).
Members of PPL-WG are invited to a dinner on the evening of September 12.

VASCERN will  be represented at this event.

For more information, click here 

The International Summer School on Rare Disease Registries and FAIRification of Data is a part of a series of training activities proposed by the European Joint Programme on Rare Diseases (EJP RD).

For more informations : click here 

The European Biotech Week celebrates biotechnology, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech Week that took place in 2013 marked the 60th anniversary of this pivotal moment in history.

To have more information : click here

VASCERN's annual seminar, VASCERN Days 2019, will take place from Novembre 7-8, 2019 in Brussels Belgium!

To get more information, please click here

International Congress Of Research On Rare And Orphan Diseases co-organized with IRDiRC and EJP RD. 

• To see the agenda: click here 
• To see the time table : click here 
• To make your registration : click here 

The Ehlers-Danlos Society brings together the leading world experts to discuss the latest medical and scientific information about the Ehlers-Danlos syndromes and hypermobility spectrum disorders.

The conference covers two separate days: March 21, 2020 is Health Professionals Day and March 22, 2020, is Patients Day for those who have EDS and HSD and their families.

For both Professionals Day and Patients Day, sessions will be translated into Spanish, French, German, Dutch, and Italian.

For more information, click here.

The International Society for the Study of Vascular Anomalies (ISSVA) will host ISSVA 2020, the 23^rd  Workshop for the Study of Vascular Anomalies,  in the beautiful city of Vancouver, in British Columbia, Canada from May 12-15, 2020.  Vancouver is great site for this Workshop!  It is a city that unites an urban metropolis with the sea and mountains.  It will also be the first time since 2008 that the Workshop will be held in North America.

The Scientific Program will be a venue to present the latest advances in research and science in vascular anomalies.  It will also feature introductory and advanced sessions that attendees can use to increase their knowledge in the fundamentals and advanced topics in the field.  ISSVA 2020 will provide a multidisciplinary forum for many specialties including – but not limited to - interventional radiologists, dermatologists, plastic surgeons, ENT surgeons, oncologists, pediatricians, pediatric surgeons, and pathologists.

The ISSVA Workshop has continuously grown thanks to your dedication to the field and participation in the meeting. We invite you to participate in ISSVA 2020 to help us continue this trend of knowledge sharing through oral presentations, difficult cases, and poster sessions.

The 10th European Conference on Rare Diseases & Orphan Products (ECRD 2020) will be held at the Stockholmsmässan Congress Center in Stockholm, Sweden on 15 to 16 May 2020.

ECRD is a biennial event that has allowed the rare disease community to gather since 2001 to monitor and benchmark relevant initiatives, drive the policy framework around rare disease diagnosis, treatment and care and empower the rare disease community to drive change where it is needed most.  Outputs from these conferences have informed national and local policy initiatives and are referenced in decision-making around the provision of services for the community.

The overarching theme for this conference is The rare disease patient journey in 2030. We will address the issues that matter today to rare disease patients and those who support them, while also anticipating the needs of tomorrow's rare disease patients and families so that innovative and sustainable responses can begin to be developed.

The European Joint Programme on Rare Diseases serves as official partner of the conference. For more information, click here.